Previously, we identified the bile acid CDCA-24G as a selective and sensitive biomarker of hepatic Oatp1b2 function in mice and of OATP1B1/OATP1B3 function in patients with cancer (30). This evidence concerns the gene SLCO1B3 and cancer.